Samsung Bioepis seeks Europe approval for its Humira copy

SEOUL, July 18 (Reuters) - Biosimilars maker Samsung

Bioepis, part of South Korea's top family-run conglomerate

Samsung Group, said on Monday it is seeking regulatory

approval in Europe to sell its copy of AbbVie Inc's

rheumatoid arthritis drug Humira.

Read more

UPDATE 1-Samsung Bioepis seeks Europe approval for its Humira copy

* European Medicines Agency reviewing Samsung Bioepis'

application

Read more

Wall St Week Ahead-Can stocks stay at highs? That depends on earnings

NEW YORK, July 15 (Reuters) - After finally eclipsing

year-old record highs, the U.S. stock market will be tested

again next week, when the onslaught of company earnings could

help investors assess the impact of Britain's vote to exit the

European Union.

Read more

First delivery of Airbus A320neo to Pegasus postponed after Turkish coup bid

PARIS, July 16 (Reuters) - The first delivery of a new

version of Airbus's A320 jet to Pegasus Airlines has been

postponed following the thwarted coup attempt in Turkey, the

European planemaker said on Saturday.

Read more

BRIEF-FDA issues complete response letter for SequestOx

* FDA issues complete response letter for Sequestox new

drug application

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more

BRIEF-Zhenxing Biopharmaceutical & Chemical says lawsuit of unit

July 16 (Reuters) - Zhenxing Biopharmaceutical & Chemical

Inc :

Read more

Pernix in talks with creditors about debt restrucuturing-sources

July 15 (Reuters) - Pernix Therapeutics Holdings Inc

has started negotiations with its creditors to potentially

restructure its debt, according to people familiar with the

matter, in the latest sign of distress in the specialty

pharmaceutical sector.

Read more